 | • レポートコード：B-GIR08C1834 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ドルテグラビル及び併用薬の世界市場について調べ、まとめました。種類別セグメントは、ドルテグラビル、アバカビル/ドルテグラビル/ラミブジン、ドルテグラビル/リルピビリン等、用途別セグメントは、医療産業、IT産業、サービス産業等に区分しました。ドルテグラビル及び併用薬の世界市場概観、企業動向、企業別ドルテグラビル及び併用薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ドルテグラビル及び併用薬の市場概観 ・ドルテグラビル及び併用薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ドルテグラビル及び併用薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・ドルテグラビル及び併用薬の世界市場規模 ・ドルテグラビル及び併用薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・ドルテグラビル及び併用薬のアメリカ市場規模推移 ・ドルテグラビル及び併用薬のカナダ市場規模推移 ・ドルテグラビル及び併用薬のメキシコ市場規模推移 ・ドルテグラビル及び併用薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ドルテグラビル及び併用薬のドイツ市場規模推移 ・ドルテグラビル及び併用薬のイギリス市場規模推移 ・ドルテグラビル及び併用薬のロシア市場規模推移 ・ドルテグラビル及び併用薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ドルテグラビル及び併用薬の日本市場規模推移 ・ドルテグラビル及び併用薬の中国市場規模推移 ・ドルテグラビル及び併用薬の韓国市場規模推移 ・ドルテグラビル及び併用薬のインド市場規模推移 ・ドルテグラビル及び併用薬の東南アジア市場規模推移 ・ドルテグラビル及び併用薬の南米市場分析（ブラジル、アルゼンチン等） ・ドルテグラビル及び併用薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ドルテグラビル及び併用薬の種類別分析/販売量、売上、市場シェア（ドルテグラビル、アバカビル/ドルテグラビル/ラミブジン、ドルテグラビル/リルピビリン） ・ドルテグラビル及び併用薬の用途別分析/市場規模（医療産業、IT産業、サービス産業） ・ドルテグラビル及び併用薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ドルテグラビル及び併用薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Dolutegravir and Its Combination Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Dolutegravir and Its Combination Drug.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Dolutegravir and Its Combination Drug market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Dolutegravir and Its Combination Drug market by product type and applications/end industries.
Market Segment by Companies, this report covers
ViiV Healthcare (GSK)
Adcock Ingram Limited
Aurobindo Pharma
Cipla
Emcure Pharmaceuticals
LAURUS Labs
Mylan
Ranbaxy Pharmaceuticals
Shanghai Desano Pharmaceuticals
JNJ
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Dolutegravir
Abacavir/Dolutegravir/Lamivudine
Dolutegravir/Rilpivirine
Market Segment by Applications, can be divided into
Hospital
Clinic
Drug Center
Other
Table of Contents
1 Dolutegravir and Its Combination Drug Market Overview
1.1 Product Overview and Scope of Dolutegravir and Its Combination Drug
1.2 Classification of Dolutegravir and Its Combination Drug by Types
1.2.1 Global Dolutegravir and Its Combination Drug Revenue Comparison by Types (2019-2024)
1.2.2 Global Dolutegravir and Its Combination Drug Revenue Market Share by Types in 2018
1.2.3 Dolutegravir
1.2.4 Abacavir/Dolutegravir/Lamivudine
1.2.5 Dolutegravir/Rilpivirine
1.3 Global Dolutegravir and Its Combination Drug Market by Application
1.3.1 Global Dolutegravir and Its Combination Drug Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Center
1.3.5 Other
1.4 Global Dolutegravir and Its Combination Drug Market by Regions
1.4.1 Global Dolutegravir and Its Combination Drug Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Dolutegravir and Its Combination Drug Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Dolutegravir and Its Combination Drug Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Dolutegravir and Its Combination Drug Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Dolutegravir and Its Combination Drug Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Dolutegravir and Its Combination Drug Status and Prospect (2014-2024)
1.5 Global Market Size of Dolutegravir and Its Combination Drug (2014-2024)
2 Manufacturers Profiles
2.1 ViiV Healthcare (GSK)
2.1.1 Business Overview
2.1.2 Dolutegravir and Its Combination Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 ViiV Healthcare (GSK) Dolutegravir and Its Combination Drug Revenue, Gross Margin and Market Share (2017-2018)
2.2 Adcock Ingram Limited
2.2.1 Business Overview
2.2.2 Dolutegravir and Its Combination Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Adcock Ingram Limited Dolutegravir and Its Combination Drug Revenue, Gross Margin and Market Share (2017-2018)
2.3 Aurobindo Pharma
2.3.1 Business Overview
2.3.2 Dolutegravir and Its Combination Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Aurobindo Pharma Dolutegravir and Its Combination Drug Revenue, Gross Margin and Market Share (2017-2018)
2.4 Cipla
2.4.1 Business Overview
2.4.2 Dolutegravir and Its Combination Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Cipla Dolutegravir and Its Combination Drug Revenue, Gross Margin and Market Share (2017-2018)
2.5 Emcure Pharmaceuticals
2.5.1 Business Overview
2.5.2 Dolutegravir and Its Combination Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Emcure Pharmaceuticals Dolutegravir and Its Combination Drug Revenue, Gross Margin and Market Share (2017-2018)
2.6 LAURUS Labs
2.6.1 Business Overview
2.6.2 Dolutegravir and Its Combination Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 LAURUS Labs Dolutegravir and Its Combination Drug Revenue, Gross Margin and Market Share (2017-2018)
2.7 Mylan
2.7.1 Business Overview
2.7.2 Dolutegravir and Its Combination Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Mylan Dolutegravir and Its Combination Drug Revenue, Gross Margin and Market Share (2017-2018)
2.8 Ranbaxy Pharmaceuticals
2.8.1 Business Overview
2.8.2 Dolutegravir and Its Combination Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Ranbaxy Pharmaceuticals Dolutegravir and Its Combination Drug Revenue, Gross Margin and Market Share (2017-2018)
2.9 Shanghai Desano Pharmaceuticals
2.9.1 Business Overview
2.9.2 Dolutegravir and Its Combination Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Shanghai Desano Pharmaceuticals Dolutegravir and Its Combination Drug Revenue, Gross Margin and Market Share (2017-2018)
2.10 JNJ
2.10.1 Business Overview
2.10.2 Dolutegravir and Its Combination Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 JNJ Dolutegravir and Its Combination Drug Revenue, Gross Margin and Market Share (2017-2018)
3 Global Dolutegravir and Its Combination Drug Market Competition, by Players
3.1 Global Dolutegravir and Its Combination Drug Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Dolutegravir and Its Combination Drug Players Market Share
3.2.2 Top 10 Dolutegravir and Its Combination Drug Players Market Share
3.3 Market Competition Trend
4 Global Dolutegravir and Its Combination Drug Market Size by Regions
4.1 Global Dolutegravir and Its Combination Drug Revenue and Market Share by Regions
4.2 North America Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
4.3 Europe Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
4.5 South America Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
5 North America Dolutegravir and Its Combination Drug Revenue by Countries
5.1 North America Dolutegravir and Its Combination Drug Revenue by Countries (2014-2019)
5.2 USA Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
5.3 Canada Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
5.4 Mexico Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
6 Europe Dolutegravir and Its Combination Drug Revenue by Countries
6.1 Europe Dolutegravir and Its Combination Drug Revenue by Countries (2014-2019)
6.2 Germany Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
6.3 UK Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
6.4 France Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
6.5 Russia Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
6.6 Italy Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Dolutegravir and Its Combination Drug Revenue by Countries
7.1 Asia-Pacific Dolutegravir and Its Combination Drug Revenue by Countries (2014-2019)
7.2 China Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
7.3 Japan Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
7.4 Korea Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
7.5 India Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
8 South America Dolutegravir and Its Combination Drug Revenue by Countries
8.1 South America Dolutegravir and Its Combination Drug Revenue by Countries (2014-2019)
8.2 Brazil Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
8.3 Argentina Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
8.4 Colombia Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Dolutegravir and Its Combination Drug by Countries
9.1 Middle East and Africa Dolutegravir and Its Combination Drug Revenue by Countries (2014-2019)
9.2 Saudi Arabia Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
9.3 UAE Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
9.4 Egypt Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
9.5 Nigeria Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
9.6 South Africa Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
10 Global Dolutegravir and Its Combination Drug Market Segment by Type
10.1 Global Dolutegravir and Its Combination Drug Revenue and Market Share by Type (2014-2019)
10.2 Global Dolutegravir and Its Combination Drug Market Forecast by Type (2019-2024)
10.3 Dolutegravir Revenue Growth Rate (2014-2024)
10.4 Abacavir/Dolutegravir/Lamivudine Revenue Growth Rate (2014-2024)
10.5 Dolutegravir/Rilpivirine Revenue Growth Rate (2014-2024)
11 Global Dolutegravir and Its Combination Drug Market Segment by Application
11.1 Global Dolutegravir and Its Combination Drug Revenue Market Share by Application (2014-2019)
11.2 Dolutegravir and Its Combination Drug Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Clinic Revenue Growth (2014-2019)
11.5 Drug Center Revenue Growth (2014-2019)
11.6 Other Revenue Growth (2014-2019)
12 Global Dolutegravir and Its Combination Drug Market Size Forecast (2019-2024)
12.1 Global Dolutegravir and Its Combination Drug Market Size Forecast (2019-2024)
12.2 Global Dolutegravir and Its Combination Drug Market Forecast by Regions (2019-2024)
12.3 North America Dolutegravir and Its Combination Drug Revenue Market Forecast (2019-2024)
12.4 Europe Dolutegravir and Its Combination Drug Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Dolutegravir and Its Combination Drug Revenue Market Forecast (2019-2024)
12.6 South America Dolutegravir and Its Combination Drug Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Dolutegravir and Its Combination Drug Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Dolutegravir and Its Combination Drug Picture
Table Product Specifications of Dolutegravir and Its Combination Drug
Table Global Dolutegravir and Its Combination Drug and Revenue (Million USD) Market Split by Product Type
Figure Global Dolutegravir and Its Combination Drug Revenue Market Share by Types in 2018
Figure Dolutegravir Picture
Figure Abacavir/Dolutegravir/Lamivudine Picture
Figure Dolutegravir/Rilpivirine Picture
Table Global Dolutegravir and Its Combination Drug Revenue (Million USD) by Application (2014-2024)
Figure Dolutegravir and Its Combination Drug Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure Drug Center Picture
Figure Other Picture
Table Global Market Dolutegravir and Its Combination Drug Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Dolutegravir and Its Combination Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Dolutegravir and Its Combination Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Dolutegravir and Its Combination Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Dolutegravir and Its Combination Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Dolutegravir and Its Combination Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Dolutegravir and Its Combination Drug Revenue (Million USD) and Growth Rate (2014-2024)
Table ViiV Healthcare (GSK) Basic Information, Manufacturing Base and Competitors
Table ViiV Healthcare (GSK) Dolutegravir and Its Combination Drug Type and Applications
Table ViiV Healthcare (GSK) Dolutegravir and Its Combination Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Adcock Ingram Limited Basic Information, Manufacturing Base and Competitors
Table Adcock Ingram Limited Dolutegravir and Its Combination Drug Type and Applications
Table Adcock Ingram Limited Dolutegravir and Its Combination Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table Aurobindo Pharma Dolutegravir and Its Combination Drug Type and Applications
Table Aurobindo Pharma Dolutegravir and Its Combination Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla Dolutegravir and Its Combination Drug Type and Applications
Table Cipla Dolutegravir and Its Combination Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Emcure Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Emcure Pharmaceuticals Dolutegravir and Its Combination Drug Type and Applications
Table Emcure Pharmaceuticals Dolutegravir and Its Combination Drug Revenue, Gross Margin and Market Share (2017-2018)
Table LAURUS Labs Basic Information, Manufacturing Base and Competitors
Table LAURUS Labs Dolutegravir and Its Combination Drug Type and Applications
Table LAURUS Labs Dolutegravir and Its Combination Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Dolutegravir and Its Combination Drug Type and Applications
Table Mylan Dolutegravir and Its Combination Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Ranbaxy Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ranbaxy Pharmaceuticals Dolutegravir and Its Combination Drug Type and Applications
Table Ranbaxy Pharmaceuticals Dolutegravir and Its Combination Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Shanghai Desano Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Shanghai Desano Pharmaceuticals Dolutegravir and Its Combination Drug Type and Applications
Table Shanghai Desano Pharmaceuticals Dolutegravir and Its Combination Drug Revenue, Gross Margin and Market Share (2017-2018)
Table JNJ Basic Information, Manufacturing Base and Competitors
Table JNJ Dolutegravir and Its Combination Drug Type and Applications
Table JNJ Dolutegravir and Its Combination Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Global Dolutegravir and Its Combination Drug Revenue (Million USD) by Players (2014-2019)
Table Global Dolutegravir and Its Combination Drug Revenue Share by Players (2014-2019)
Figure Global Dolutegravir and Its Combination Drug Revenue Share by Players in 2017
Figure Global Dolutegravir and Its Combination Drug Revenue Share by Players in 2018
Figure Global Top 5 Players Dolutegravir and Its Combination Drug Revenue Market Share in 2018
Figure Global Top 10 Players Dolutegravir and Its Combination Drug Revenue Market Share in 2018
Figure Global Dolutegravir and Its Combination Drug Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Dolutegravir and Its Combination Drug Revenue (Million USD) by Regions (2014-2019)
Table Global Dolutegravir and Its Combination Drug Revenue Market Share by Regions (2014-2019)
Figure Global Dolutegravir and Its Combination Drug Revenue Market Share by Regions (2014-2019)
Figure Global Dolutegravir and Its Combination Drug Revenue Market Share by Regions in 2018
Figure North America Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Figure Europe Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Figure South America Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Table North America Dolutegravir and Its Combination Drug Revenue by Countries (2014-2019)
Table North America Dolutegravir and Its Combination Drug Revenue Market Share by Countries (2014-2019)
Figure North America Dolutegravir and Its Combination Drug Revenue Market Share by Countries (2014-2019)
Figure North America Dolutegravir and Its Combination Drug Revenue Market Share by Countries in 2018
Figure USA Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Figure Canada Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Figure Mexico Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Table Europe Dolutegravir and Its Combination Drug Revenue (Million USD) by Countries (2014-2019)
Figure Europe Dolutegravir and Its Combination Drug Revenue Market Share by Countries (2014-2019)
Figure Europe Dolutegravir and Its Combination Drug Revenue Market Share by Countries in 2018
Figure Germany Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Figure UK Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Figure France Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Figure Russia Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Figure Italy Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Dolutegravir and Its Combination Drug Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Dolutegravir and Its Combination Drug Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Dolutegravir and Its Combination Drug Revenue Market Share by Countries in 2018
Figure China Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Figure Japan Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Figure Korea Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Figure India Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Table South America Dolutegravir and Its Combination Drug Revenue by Countries (2014-2019)
Table South America Dolutegravir and Its Combination Drug Revenue Market Share by Countries (2014-2019)
Figure South America Dolutegravir and Its Combination Drug Revenue Market Share by Countries (2014-2019)
Figure South America Dolutegravir and Its Combination Drug Revenue Market Share by Countries in 2018
Figure Brazil Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Figure Argentina Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Figure Colombia Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Dolutegravir and Its Combination Drug Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Dolutegravir and Its Combination Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Dolutegravir and Its Combination Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Dolutegravir and Its Combination Drug Revenue Market Share by Countries in 2018
Figure Saudi Arabia Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Figure UAE Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Figure Egypt Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Figure Nigeria Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Figure South Africa Dolutegravir and Its Combination Drug Revenue and Growth Rate (2014-2019)
Table Global Dolutegravir and Its Combination Drug Revenue (Million USD) by Type (2014-2019)
Table Global Dolutegravir and Its Combination Drug Revenue Share by Type (2014-2019)
Figure Global Dolutegravir and Its Combination Drug Revenue Share by Type (2014-2019)
Figure Global Dolutegravir and Its Combination Drug Revenue Share by Type in 2018
Table Global Dolutegravir and Its Combination Drug Revenue Forecast by Type (2019-2024)
Figure Global Dolutegravir and Its Combination Drug Market Share Forecast by Type (2019-2024)
Figure Global Dolutegravir Revenue Growth Rate (2014-2019)
Figure Global Abacavir/Dolutegravir/Lamivudine Revenue Growth Rate (2014-2019)
Figure Global Dolutegravir/Rilpivirine Revenue Growth Rate (2014-2019)
Table Global Dolutegravir and Its Combination Drug Revenue by Application (2014-2019)
Table Global Dolutegravir and Its Combination Drug Revenue Share by Application (2014-2019)
Figure Global Dolutegravir and Its Combination Drug Revenue Share by Application (2014-2019)
Figure Global Dolutegravir and Its Combination Drug Revenue Share by Application in 2018
Table Global Dolutegravir and Its Combination Drug Revenue Forecast by Application (2019-2024)
Figure Global Dolutegravir and Its Combination Drug Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Clinic Revenue Growth Rate (2014-2019)
Figure Global Drug Center Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Dolutegravir and Its Combination Drug Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Dolutegravir and Its Combination Drug Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Dolutegravir and Its Combination Drug Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Dolutegravir and Its Combination Drug Revenue Market Forecast (2019-2024)
Figure Europe Dolutegravir and Its Combination Drug Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Dolutegravir and Its Combination Drug Revenue Market Forecast (2019-2024)
Figure South America Dolutegravir and Its Combination Drug Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Dolutegravir and Its Combination Drug Revenue Market Forecast (2019-2024)
ドルテグラビル/リルピビリン配合薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Dolutegravir/Rilpivirine Combination Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on t…- ドルテグラビルの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Dolutegravir is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Dolutegravir in global mar…
- ドルテグラビルナトリウムの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Dolutegravir Sodium is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Dolutegravir Sodium…
- テノホビル/エムトリシタビン配合剤の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Tenofovir/Emtricitabine Combination Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on th…
- エファビレンツ/テノホビル/エムトリシタビン配合薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Efavirenz/Tenofovir/Emtricitabine Combination Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report foc…